265 related articles for article (PubMed ID: 26268558)
1. The solution structures of native and patient monomeric human IgA1 reveal asymmetric extended structures: implications for function and IgAN disease.
Hui GK; Wright DW; Vennard OL; Rayner LE; Pang M; Yeo SC; Gor J; Molyneux K; Barratt J; Perkins SJ
Biochem J; 2015 Oct; 471(2):167-85. PubMed ID: 26268558
[TBL] [Abstract][Full Text] [Related]
2. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
Boehm MK; Woof JM; Kerr MA; Perkins SJ
J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
[TBL] [Abstract][Full Text] [Related]
3. Solution structure determination of monomeric human IgA2 by X-ray and neutron scattering, analytical ultracentrifugation and constrained modelling: a comparison with monomeric human IgA1.
Furtado PB; Whitty PW; Robertson A; Eaton JT; Almogren A; Kerr MA; Woof JM; Perkins SJ
J Mol Biol; 2004 May; 338(5):921-41. PubMed ID: 15111057
[TBL] [Abstract][Full Text] [Related]
4. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions.
Mattu TS; Pleass RJ; Willis AC; Kilian M; Wormald MR; Lellouch AC; Rudd PM; Woof JM; Dwek RA
J Biol Chem; 1998 Jan; 273(4):2260-72. PubMed ID: 9442070
[TBL] [Abstract][Full Text] [Related]
5. Purification, properties and extended solution structure of the complex formed between human immunoglobulin A1 and human serum albumin by scattering and ultracentrifugation.
Almogren A; Furtado PB; Sun Z; Perkins SJ; Kerr MA
J Mol Biol; 2006 Feb; 356(2):413-31. PubMed ID: 16376934
[TBL] [Abstract][Full Text] [Related]
6. Semi-extended solution structure of human myeloma immunoglobulin D determined by constrained X-ray scattering.
Sun Z; Almogren A; Furtado PB; Chowdhury B; Kerr MA; Perkins SJ
J Mol Biol; 2005 Oct; 353(1):155-73. PubMed ID: 16157351
[TBL] [Abstract][Full Text] [Related]
7. The Fab conformations in the solution structure of human immunoglobulin G4 (IgG4) restrict access to its Fc region: implications for functional activity.
Rayner LE; Hui GK; Gor J; Heenan RK; Dalby PA; Perkins SJ
J Biol Chem; 2014 Jul; 289(30):20740-56. PubMed ID: 24876381
[TBL] [Abstract][Full Text] [Related]
8. Irreversible aggregation of the Fc fragment derived from polymeric but not monomeric serum IgA1--implications in IgA-mediated disease.
Almogren A; Kerr MA
Mol Immunol; 2008 Jan; 45(1):87-94. PubMed ID: 17606293
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
Gastaldi D; Paradisi L; Baiocchi C; Medana C; Lo Duca G; Sena LM; Roccatello D
J Nephrol; 2007; 20(6):689-95. PubMed ID: 18046671
[TBL] [Abstract][Full Text] [Related]
10. The solution structure of the human IgG2 subclass is distinct from those for human IgG1 and IgG4 providing an explanation for their discrete functions.
Hui GK; Gardener AD; Begum H; Eldrid C; Thalassinos K; Gor J; Perkins SJ
J Biol Chem; 2019 Jul; 294(28):10789-10806. PubMed ID: 31088911
[TBL] [Abstract][Full Text] [Related]
11. Solution structures of human myeloma IgG3 antibody reveal extended Fab and Fc regions relative to the other IgG subclasses.
Spiteri VA; Goodall M; Doutch J; Rambo RP; Gor J; Perkins SJ
J Biol Chem; 2021 Sep; 297(3):100995. PubMed ID: 34302810
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
Hiki Y; Odani H; Takahashi M; Yasuda Y; Nishimoto A; Iwase H; Shinzato T; Kobayashi Y; Maeda K
Kidney Int; 2001 Mar; 59(3):1077-85. PubMed ID: 11231363
[TBL] [Abstract][Full Text] [Related]
13. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
Leung JC; Poon PY; Lai KN
J Lab Clin Med; 1999 Feb; 133(2):152-60. PubMed ID: 9989767
[TBL] [Abstract][Full Text] [Related]
14. Implications of the near-planar solution structure of human myeloma dimeric IgA1 for mucosal immunity and IgA nephropathy.
Bonner A; Furtado PB; Almogren A; Kerr MA; Perkins SJ
J Immunol; 2008 Jan; 180(2):1008-18. PubMed ID: 18178841
[TBL] [Abstract][Full Text] [Related]
15. O-glycosylation of serum IgD in IgA nephropathy.
Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
[TBL] [Abstract][Full Text] [Related]
16. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry.
Odani H; Hiki Y; Takahashi M; Nishimoto A; Yasuda Y; Iwase H; Shinzato T; Maeda K
Biochem Biophys Res Commun; 2000 Apr; 271(1):268-74. PubMed ID: 10777713
[TBL] [Abstract][Full Text] [Related]
17. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
[TBL] [Abstract][Full Text] [Related]
18. Masking of the Fc region in human IgG4 by constrained X-ray scattering modelling: implications for antibody function and therapy.
Abe Y; Gor J; Bracewell DG; Perkins SJ; Dalby PA
Biochem J; 2010 Nov; 432(1):101-11. PubMed ID: 20722630
[TBL] [Abstract][Full Text] [Related]
19. Demonstration by pulsed neutron scattering that the arrangement of the Fab and Fc fragments in the overall structures of bovine IgG1 and IgG2 in solution is similar.
Mayans MO; Coadwell WJ; Beale D; Symons DB; Perkins SJ
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):283-91. PubMed ID: 7575466
[TBL] [Abstract][Full Text] [Related]
20. Separation of Two Distinct O-Glycoforms of Human IgA1 by Serial Lectin Chromatography Followed by Mass Spectrometry O-Glycan Analysis.
Lehoux S; Ju T
Methods Enzymol; 2017; 585():61-75. PubMed ID: 28109443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
